Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
Biologics dont need long market exclusivity, FTC says
American Medical News , 06/30/09
Trapp D - A recent Federal Trade Commission report asserting that original biopharmaceutical drug manufacturers do not need lengthy exclusive marketing periods to maintain innovation has not driven supporters from a bill that would extend such protection.
Related Articles
Nabi Biopharmaceuticals to Hold Conference Call
Nabi Biopharmaceuticals, 11/17/09
Relevance Score: 87%
Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement on Rheumatoid Arthritis Biologic
Bristol Myers-Squibb Company, 11/11/09
Relevance Score: 84%
Nabi Biopharmaceuticals Participates in NicVAX(R) Phase IIb Study
Nabi Biopharmaceuticals, 10/29/09
Relevance Score: 84%
Nabi Biopharmaceuticals to Announce Third Quarter Financial Results on November 2009
Nabi Biopharmaceuticals, 10/28/09
Relevance Score: 84%
Sanofi-aventis to acquire FOVEA, a French biopharmaceutical ophthalmology company
Sanofi-aventis, 10/02/09
Relevance Score: 84%
Today in Law/Ethics/Regulations...keeping you current
Receive free subspecialty "5-minute updates" via email
Ten reasons to oppose the criminalization of HIV exposure or transmission
Reproductive Health Matters, 12/14/09
Vertical HIV transmission should be excluded from criminal prosecution
Reproductive Health Matters, 12/14/09
More time to comply with Medicare enrollment policy
American Medical News , 12/11/09
Article Search
Sponsor


See Latest Articles


